1. Counseling Patients About Germline BRCA Mutations

3. Risk of Malignancy in Persons With a Germline BRCA1 or BRCA2 Pathogenic Variant

4. Rationale for Genetic Testing for BRCA Mutation

5. Approaches to Molecular Testing

6. Genetic Testing Guidelines for Ovarian Cancer

7. BRCA1/2 Testing Criteria

8. BRCA1/2 Testing Criteria (cont)

9. Patient Education About Genetic Testing

10. Possible Test Results

11. Patient Education After Genetic Testing

12. Implications for Family Members

13. Management Considerations

14. Management Considerations (cont)

15. Management Considerations: PARP Inhibitor Therapy for Ovarian Cancer

16. Follow-Up Discussions

17. Summary

18. Resources for Clinicians and Patients

19. Abbreviations